Shanghai Shenqi Pharmaceutical Investment Management Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Shenqi Pharmaceutical Investment Management has a total shareholder equity of CN¥2.4B and total debt of CN¥236.0M, which brings its debt-to-equity ratio to 9.9%. Its total assets and total liabilities are CN¥3.3B and CN¥888.8M respectively. Shanghai Shenqi Pharmaceutical Investment Management's EBIT is CN¥116.5M making its interest coverage ratio -143.8. It has cash and short-term investments of CN¥736.2M.
Key information
9.9%
Debt to equity ratio
CN¥236.04m
Debt
| Interest coverage ratio | -143.8x |
| Cash | CN¥736.17m |
| Equity | CN¥2.39b |
| Total liabilities | CN¥888.77m |
| Total assets | CN¥3.28b |
Financial Position Analysis
Short Term Liabilities: 600613's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥686.0M).
Long Term Liabilities: 600613's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥202.7M).
Debt to Equity History and Analysis
Debt Level: 600613 has more cash than its total debt.
Reducing Debt: 600613's debt to equity ratio has increased from 0% to 9.9% over the past 5 years.
Debt Coverage: 600613's debt is well covered by operating cash flow (91.3%).
Interest Coverage: 600613 earns more interest than it pays, so coverage of interest payments is not a concern.